Melar Acquisition Corp. I (MACI) is a special purpose acquisition company (SPAC) dedicated to identifying and merging with high-growth companies in the technology and healthcare sectors. Led by an experienced management team, MACI aims to capitalize on its industry knowledge to target innovative firms positioned for significant market expansion. By focusing on transformative industries, MACI offers institutional investors an attractive opportunity to participate in the evolution of key market players that are driving forward progress and value creation.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.75% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.36 |
| Price-to-Book | 1.43 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 44.15 |
| Quarterly Earnings Growth (YoY) | -50.70% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $21.62M |
| Float | $13.03M |
| % Insiders | 0.00% |
| % Institutions | 397.89% |
Volatility is currently expanding
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MACI and any ticker you trade — then tracks every position and per-strategy win rate.